Your browser doesn't support javascript.
loading
Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study.
Sunata, Keeya; Miyata, Jun; Terai, Hideki; Matsuyama, Emiko; Watase, Mayuko; Namkoong, Ho; Asakura, Takanori; Masaki, Katsunori; Chubachi, Shotaro; Ohgino, Keiko; Kawada, Ichiro; Harada, Norihiro; Sasano, Hitoshi; Nakamura, Ai; Kusaka, Yu; Ohba, Takehiko; Nakano, Yasushi; Nishio, Kazumi; Nakajima, Yukiko; Suzuki, Shoji; Yoshida, Shuichi; Tateno, Hiroki; Ishii, Makoto; Fukunaga, Koichi.
  • Sunata K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Miyata J; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. Electronic address: junmiyata.a2@keio.jp.
  • Terai H; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
  • Matsuyama E; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Watase M; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Department of Respiratory Medicine, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Namkoong H; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
  • Asakura T; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan; Department of Clinical Medicine (Laboratory of Bioregulatory Medicine), Kitasato University Sch
  • Masaki K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Chubachi S; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Ohgino K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kawada I; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Research Centers and Institutes, Health Center, Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Harada N; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
  • Sasano H; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
  • Nakamura A; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
  • Kusaka Y; Department of Respiratory Medicine, Ome Municipal General Hospital, Tokyo, Japan.
  • Ohba T; Department of Respiratory Medicine, Ome Municipal General Hospital, Tokyo, Japan.
  • Nakano Y; Department of Internal Medicine, Kawasaki Municipal Ida Hospital, Kanagawa, Japan.
  • Nishio K; Department of Internal Medicine, Kawasaki Municipal Ida Hospital, Kanagawa, Japan.
  • Nakajima Y; Department of Internal Medicine, Kawasaki Municipal Ida Hospital, Kanagawa, Japan.
  • Suzuki S; Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.
  • Yoshida S; Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.
  • Tateno H; Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.
  • Ishii M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fukunaga K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Allergol Int ; 73(2): 206-213, 2024 Apr.
Article en En | MEDLINE | ID: mdl-37996384
ABSTRACT

BACKGROUND:

Multiple prolonged symptoms are observed in patients who recover from an acute COVID-19 infection, which is defined as long COVID. General fatigue is frequently observed in patients with long COVID during acute and post-acute phases. This study aimed to identify the specific risk factors for general fatigue in long COVID.

METHODS:

Hospitalized patients with COVID-19 aged over 18 years were enrolled in a multicenter cohort study at 26 medical institutions. Clinical data during hospitalization and patient-reported outcomes after discharge were collected from medical records, paper-based questionnaires, and smartphone apps.

RESULTS:

Among prolonged symptoms through 1-year follow-ups, general fatigue was the most interfering symptom in daily life. Patients with protracted fatigue at all follow-up periods had lower quality of life scores at the 12-month follow-up. Univariate logistic regression analysis of the presence or absence of general fatigue at the 3-month, 6-month, and 12-month follow-ups identified asthma, younger age, and female sex as risk factors for prolonged fatigue. Multivariable logistic regression analysis revealed that asthma was an independent risk factor for persistent fatigue during the 12-month follow-up period. Longitudinal changes in the symptoms of patients with or without asthma demonstrated that general fatigue, not cough and dyspnea, was significantly prolonged in patients with asthma.

CONCLUSIONS:

In a Japanese population with long COVID, prolonged general fatigue was closely linked to asthma. A preventive approach against COVID-19 is necessary to avoid sustained fatigue and minimize social and economic losses in patients with asthma.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / COVID-19 Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / COVID-19 Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article